Study on Nonmyeloablative Bone Marrow Transplantation

陈字,谢彦晖,陈彤,袁燕,叶静,谢毅
DOI: https://doi.org/10.3969/j.issn.1672-8467.2004.05.021
2004-01-01
Abstract:Purpose: To establish mouse model of nonmyeloablative bone marrow transplantation, to explore the feasibility of engraftment of allogeneic bone marrow after nonmyeloablative pretreatment, and to explore the relation between the number of transplanted allogeneic bone marrow hematopoietic cells and engraftment of allogeneic bone marrow transplantation. Methods: We used C57BL/6 female mice as recipients and used BALB/c male mice as donors. The recipients received Cyclophosphamide(200 mg/kg) and total body irradiation (5Gy). This regime of pretreatment was nonmyeloablative. The recipients mice were divided into three groups: A, B and C group. There were ten mice in each group. The mice of A, B and C group received injection of 2 × 107, 8 × 106 and 2 × 106 allogeneic bone marrow cells, respectively. On the 36th day after transplantation, we detected the Y chromosome specific gene in bone marrow cells of recipients mice to determine the engraftment of allogeneic bone marrow. Results: In A, B and C groups, we found eight, three and zero allogeneic cherism mice. Conclusions: Engraftment of allogeneic hematopoietic cells can be successful after nonmyeloablative pretreatment. Escalation of hematopoietic progenitor cells can overcome the barrier of major histocompatibility complex (MHC) between donor and recipient and enable the engraftment.
What problem does this paper attempt to address?